Drug intelligence / Profile preview

rhCollagen

Development stage
Preclinical
Lead developer
CollPlant Biotechnologies
Modality
Recombinant Proteins and Enzymes
Administration
Intradermal, Subcutaneous, Topical, Surgical Implantation
01

Overview

rhCollagen is a recombinant form of human type I collagen produced using genetically engineered tobacco plants. The process involves introducing synthetic human genes into the plants to express procollagen, which is then extracted and purified. This plant-derived rhCollagen is structurally and biochemically identical to natural human type I collagen and does not elicit an adverse immune response in humans. Its consistent properties and safety profile make it an ideal building block for regenerative medicine applications such as 3D bioprinting of tissues and organs, medical aesthetics (including dermal fillers), wound healing, cell culture media, tissue engineering scaffolds, and soft tissue reconstruction. CollPlant’s rhCollagen technology platform enables the development of products with superior biological performance compared to animal- or cadaver-sourced collagens[1][3][5][7].

Brand names
VergenixFGVergenixSTR
Other names
recombinant human collagenrecombinant human type I collagenplant-derived recombinant human collagenrhCol III
02

Targets

Neuraminidase

Beyond the preview

Go deeper on rhCollagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rhCollagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call